A study evaluating the expression of SOX2 in oral squamous cell carcinomas has shown that a tumor with a high nuclear expression of SOX2 had longer disease-free survival period following postoperative radiotherapy.5 The gene discussed is SOX2; the disease is oral cavity squamous cell carcinoma.